JCO Precision Oncology @JCOPO_ASCO
Original research, reports, opinions, and reviews advancing the science and practice of #precisiononcology. Part of @JCO_ASCO family of journals. ascopubs.org/journal/po Joined July 2016-
Tweets933
-
Followers5K
-
Following217
-
Likes621
#JCOPO report showing #RET fusions may be a negative prognostic factor in patients w/ solid tumors w/ further emphasis for broader genomic testing since RET-specific TKIs for these tumors may improve outcomes beyond current standard of care options. ➡️ brnw.ch/21wJeRF
Data from @AACR GENIE Biopharma Collaborative cohort show timing of NGS after diagnosis varied significantly by clinical characteristics suggesting applied researchers should examine the sensitivity of their findings to the timing of genomic sequencing. ➡️ brnw.ch/21wJdft
Across >2,500 pts w/ #mNSCLC, timely CGP before 1L initiation w/ increased targeted therapy use decreased expenditure on ICPIs among ALK/EGFR/RET/ROS1 driver-positive pts supporting importance of timely CGP to inform optimal 1L therapy selection. ➡️ brnw.ch/21wJawy #NSCLC
Read about TARGET, a randomized non-inferiority trial to compare pretest genetic education via a webtool for noninferiority to traditional genetic counseling (GC) in patients with #ProstateCancer (PCA). ➡️ brnw.ch/21wJ86I @LoebStacy @vedangiri #pcsm
#JCOPO article highlighting that the B-cell signature significantly shapes the overall tumor gene expression profile and influences patient prognosis in ER-positive #breastcancer. ➡️ brnw.ch/21wJ5o8 #bcsm
#ctDNA analysis of palbociclib-treated patients with metastatic #BreastCancer in the TREnd trial revealed an independent prognostic role of ESR1 mutations. ➡️ brnw.ch/21wJ3bB #mBC
1/2 Dual publication @JCOPO_ASCO @theNCI @eaonc NCI-MATCH Subprotocol K2 positive PhII trial ➡️ activity of #Erdafitinib in treatment-refractory tumors w/#FGFR1-3 mutations or fusions, adding to evid for potential tumor agnostic indication? ascopubs.org/doi/10.1200/PO… @OncoAlert
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2 | JCO Precision Oncology @jgong15 ascopubs.org/doi/10.1200/PO…
Wow! A lot of BRAF inhibitors in pre-clinical development @AACR #aacr24 👉Targeting All BRAF Alterations: The (Re)-Search Continues | JCO Precision Oncology @OncoAlert @JCOPO_ASCO @JCO_ASCO ascopubs.org/doi/10.1200/PO…
🎧 In this JCO Precision Oncology Conversations podcast ep, @thenasheffect speaks with Lauren C. Leiman & Dr. Emma Alme about their #JCOPO publication, “Recommendations for the Equitable and Widespread Implementation of #LiquidBiopsy for #CancerCare.” ➡️ brnw.ch/21wIwaa
Some activity noted in tumors with class II and III BRAF mutations. More research necessary!
Some activity noted in tumors with class II and III BRAF mutations. More research necessary!
🧬Peritoneal Tumor DNA-liquid biopsy (ptDNA) in gastric cancer @JCOPO_ASCO ✅Sensitivity 85.2% (66.5 to 100.0) specifity 91.5% (86.5 to 96.6), reference test: cytology 🚨8.5% of cytology-negative patients had positive ptDNA 🚨ptDNA positivity: -Risk of peritoneal-specific…
How can you critically evaluate clinical prostate cancer genomic test reports, and learn to spot red flags? Check out this piece by @G_Vandekerkhove, @vedangiri, and colleagues in @JCOPO_ASCO ascopubs.org/doi/10.1200/PO…. Thanks to @PCF_Science for support!
Report in #JCOPO from the @ASCO #TAPUR study demonstrating that regorafenib did not demonstrate antitumor activity in heavily pretreated patients w/ BRAF-mutated solid tumors: brnw.ch/21wIjfQ
#JCOPO study evaluating 99mTc-MDP bone scan index (automated bone scan index [aBSI]) and circulating tumor cell (CTC) analyses as potential biomarkers of prognosis and activity in patients with #mCRPC receiving radium-223. ➡️ brnw.ch/21wIhYs #pcsm
.@ChristianRolfo et al. demonstrate that early liquid biopsy in aNSCLC in parallel with path dx is associated with shorter time to treatment: brnw.ch/21wIgRk #LCSM
Phase 2 trial validates that trametinib plus low-dose dabrafenib is active and tolerated in adv. BRAFV600/NRASQ61 wild-type #melanoma w the highest antitumor activity observed in melanoma harboring alternative activating MAPK pathway alterations: brnw.ch/21wIfna #melsm
This #JCOPO study demonstrated that ctDNA dynamics may have limited ability to monitor therapeutic efficacy in patients with heavily pre-treated metastatic malignancies on #PARP or #VEGF inhibitors. ➡️ brnw.ch/21wIesl
NCI-MATCH Subprotocol E Phase II trial of osimertinib in non-lung pts: 15% ORR, PR in neuroendocrine and epithelial carcinoma: brnw.ch/21wIdeW @MonicaChenMD @HelenaYu923 @LeciaSequist @christine_lovly @EdithMitchellMD @CarlosArteagaMD
.@ASCO #TAPUR confirms and extends olaparib antitumor activity in pretreated patients w/ BRCA1/2 mutated #pancreaticcancer: brnw.ch/21wIcRd #pancsm
Vivek Subbiah, MD @VivekSubbiah
34K Followers 2K Following Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
ASCO @ASCO
147K Followers 2K Following Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
Pashtoon Kasi MD, MS @pashtoonkasi
18K Followers 11K Following Oncologist | Researcher | ColorectalCancer #CRCSM👨🏼🎓@MayoClinic @PittTweet Alum; 🧬#ctDNA #LiquidBiopsies💡#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO23
Jarushka Naidoo @DrJNaidoo
9K Followers 929 Following Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins University
OncLive.com @OncLive
44K Followers 2K Following Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
Ben Westphalen @BenWestphalen
4K Followers 200 Following Oncologist focused on #PrecisionOncology 🎯 & #PancreaticCancer 💜 •@myesmo PMWG chair • #MissionCancer Board🇪🇺•Rolling with @OncoAlert 🚨 •Views are my own•
Razelle Kurzrock, MD @Dr_R_Kurzrock
7K Followers 5K Following Momx7 (4 children; 3 dogs); wife; Precision/Rare diseases; MCW AD; CMO WIN; physician, not provider; Board CureMetrix/CureMatch (cofounder); opinions mine
Nirmal Raut @oncologician
6K Followers 6K Following Masters of molecular oncology (CNIO ) Medical Oncologist by profession (Lung is close to my heart), researcher by passion, precision oncology,liquid biopsy.
Sam Klempner @KlempnerSam
3K Followers 652 Following GI medical oncologist focusing on stomach and esophageal cancer research at Massachusetts General Hospital, Harvard Medical School
Petros Grivas @PGrivasMDPhD
16K Followers 12K Following Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine
Aakash Desai, MD, MPH @ADesaiMD
5K Followers 1K Following Thoracic/Phase 1 Oncologist @ONealCancerUAB, Asst Prof @UABMedicine | Alum @MayoHemeOnc @UConnIM @MDAndersonNews| Co-Host @HemOncFellows @LungCancerRX
Andres F. Cardona @AndresFCardonaZ
8K Followers 4K Following Pursue knowledge, mentor students, collaborate globally, and push boundaries. Everything else is just noise in the academic concert.
Fumiko Ladd Chino, MD @fumikochino
15K Followers 766 Following Radiation Oncologist. Reformed Artist. Cancer Widow. I study #FinancialToxicity #Affordability Access & #Equity @MSKCancerCenter 📲me COI https://t.co/NoevEyYBhy
Stephanie Graff, MD, .. @DrSGraff
19K Followers 4K Following Director Breast Oncology, Lifespan Cancer Institute, Legorreta Cancer Center Brown Univ | Medical Advisor @drloveresearch | #bcsm #clinicaltrials | Views Mine
gilberto lopes @GlopesMd
38K Followers 41K Following Chief MedOnc @SylvesterCancer @UnivMiami. Improving access to cancer meds in LMICs. Editor-in-Chief @JCOGO_ASCO, Board Member @UICC - co-chair #ATOMcoalition
Balazs Halmos @DrSteveMartin
8K Followers 3K Following Thoracic/precision oncology 🇭🇺🇺🇸 Country music singer- The White Lungs
Naoto T Ueno, MD, PhD @teamoncology
14K Followers 1K Following NCI-designated Univ of Hawai’i Cancer Ctr @UHCancerCenter, Director. Breast Med Onc. IBC. MBC. Japanese X @nuenojpn. Accounts reflect only my personal view.
Philippe Aftimos, MD .. @aftimosp
6K Followers 4K Following Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Sewanti Limaye 🇮�.. @SewantiLimaye
3K Followers 2K Following Director Medical&Precision Oncology #precisiononcology #liquidbx #hnc #LCSM @DanaFarber @ColumbiaMed @JIPOEditors @IylonOncology @rfhospital #IMPACTIndia
Dr. Cathy Eng @CathyEngMD
11K Followers 4K Following Co-Director/Co-Leader GI Oncology Research; Exec Direc Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee; and Director for Strategic Relations
florent soubrier @FlorentSoubrier
5 Followers 45 Following geneticist MD PhD professor of genetics angiogenetics oncogenetics French Paris
日本がん対策新.. @gantaisaku1105
12K Followers 614 Following がん治療の選択肢を増やすために読む新聞を書いています。どこよりも早く、３秒で分かる、治療選択に役立つ情報だけを厳選、そんな新聞。
Noémie Paillon @NoemiePaillon
1K Followers 388 Following PhD in immuno-oncology from 🇫🇷 & 🇦🇹 @Institut_Curie alumni
Andrés López-Corté.. @Andres_Lopez_C
6K Followers 6K Following 🧬 Principal Investigator, Cancer Research Group (CRG) at UDLA | Professor, Faculty of Medicine at UDLA | PhD Bioinformatics TIC | MSc Biomedicine | 🇪🇨
Rohit Rao,MD @RohitRao2100
40 Followers 132 Following Hematologist Oncologist at Mayo Clinic . Tweets/Opinions are my own and not the views of my employer. Retweets are not endorsements .
Santiago Guerrero @sxguerrero
2K Followers 931 Following PhD in Molecular and Cellular Biology. iD https://t.co/TcN25LYx4V. Alumnus @CRGenomica @unistra @PUCE_Ecuador. PI at @UIDE
Kurt Schultz @SchultzKurt
1K Followers 2K Following PGY-Lab @YaleSurgery | PhD student @YaleGSAS | @UMassChan @BostonSOAR @UMassCHC
Evan @Evan734
69 Followers 2K Following
Tia Simon @Patrici25127914
1 Followers 47 Following
Patrick K McCaffrey @PKMcCaffrey
60 Followers 276 Following
Oncology Data Advisor @OncData
403 Followers 2K Following #OncData delivers up-to-date, clinically relevant content for the multidisciplinary #cancer care team including the latest medical news, research, and more.
Vanderbilt-Ingram Can.. @VUMC_Cancer
3K Followers 559 Following NCI-designated Comprehensive Cancer Center and leader in the prevention, diagnosis and treatment of cancer. https://t.co/dAMtiFzAQR
Bcvcc0 @Bcvcc01
1 Followers 76 Following
Farnaz Z @farnaz_z_
14 Followers 320 Following
ALEJANDRA BAÑOL @ALEJANDRAB11213
2 Followers 38 Following
Irina Kerle, MD @IrieKerle
11 Followers 136 Following Medical oncologist interested in precision oncology and translational research in hematolgy/oncology
Jun Gong @jgong15
1K Followers 537 Following Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope
Aline Kozak @aline_kozak
1 Followers 17 Following
Oncology_MD1986 @OncologyMD1986
12 Followers 120 Following
Halimaet @halima54324
0 Followers 14 Following
Patrícia @Arstagradu
34 Followers 58 Following
Talia Shentzer Kutiel @Taliashentzer
38 Followers 93 Following Thoracic medical oncologist,animal lover and optimistic
Best of Oncology UK @bestoncologyuk
19 Followers 140 Following
T$ @TLeavery
82 Followers 620 Following Biotech - Health Systems, Oncology and Market Access. EBM, QI/Outcomes-based Carepaths
Prashanth Ashok Kumar @AKPOncologist
10 Followers 44 Following
Wael Abdelrahman @WaelAbd78084273
16 Followers 539 Following
mohammad sabry @mselkady
103 Followers 367 Following
Residentes Onco HSL @HslOncoResi
20 Followers 142 Following
Nikhilsinh Khant @NIKHILSINHKHANT
15 Followers 78 Following Cancer Surgeon || Surgical Oncologist ||
David Su @DavidSuMD
213 Followers 416 Following PGY3 @YaleSurgRes 🔪@UCSFMedicine @ragoninstitute @Harvard alum. Surgical oncology, researcher 🧬, father, husband, dog dad. Ideas my own.
Penn Medicine - Abram.. @PennCancer
6K Followers 1K Following Penn Medicine - Abramson Cancer Center has proudly been an NCI-designated Comprehensive Cancer Center since 1973.
Surya Narayanan @SuryaNaray52597
0 Followers 13 Following
Brandon Rose, MD, MPH @BRoseMDMPH
818 Followers 638 Following UMiami IM PGY2 🩺 Future Heme/Onc 🧫 UMiami '22 MD/MPH 🌴 UCSB '16 Cell Bio 🌊 R coder 💻 Sarcoma & Lung Cancer 🔬FCI 🚒 Marathon x7 🏃♂️ @thecodingdocs 🩺
DrBlairIrwin @drblairirwin
16 Followers 98 Following Medical Oncologist, Dedicated to reducing the burden of cancer, Boy Mom x 3, squash enthusiast, Hiker, Clinical Trialist, Opinions all my Own.
Cecilia Pompili MD Ph.. @pompili_cecilia
1K Followers 2K Following General Thoracic Surgeon, Associate Professor focusing on patient reported outcomes (PROMs) in lung cancer care @HullYorkMed @ests_womenThor
Erika Belmont @ErikaBelmont7
148 Followers 325 Following PGY3 @UChicagoMed | She/Hers | Interested in Hematology/Oncology | Opinions = Mine
Wu Gong @Gong__Wu
3 Followers 56 Following
Mark Layden @Layden_Rx
61 Followers 61 Following Pharm.D. @bjdsop | PGY-2 HSPAL Resident @mayopharmres | Mayo Clinic | Servant Leader | All thoughts are my own | #TwitteRx
Revathi_Manoharaan @Revathi_1998
13 Followers 68 Following | Ph.D. in BIOE (UIUC) | Learning to love the struggles, finding peace in failures, Cos I know, that way, I will keep moving!
Aishat @Aishaa_Onc
24 Followers 145 Following MBBS | Building @OncologyIG_ng | Aspiring oncologist #CancerResearch #Genomics #GlobalOncology
Paolo Ambrosini @Pa_Ambrosini
0 Followers 29 Following
Brian Longbottom @LongbottomBrian
50 Followers 51 Following Incoming PGY-1 @UIowa_surgery | USF Med ‘24 @USFhealthmed | Biochemistry and Molecular Biology @UF | Tweets are my own
Timika Villane @timik_villa
54 Followers 5K Following
Breast Cancer Hope He.. @BCBattleback
19 Followers 150 Following Stage 4 breast https://t.co/OJmc0nQS07 have I fought 18 years nonstop?Hope is my most powerful weapon.Find daily dose of it here:new exciting advances+ways 2 fight
Ari Hakimian @PagingDoctorAri
4 Followers 87 Following
LiaMar @LiaMar02982953
10 Followers 32 Following
Za!na Al-amer @ihua_hn
2 Followers 233 Following
M JOSE SERRANO (LB&Ca.. @MJOSESERRANO19
874 Followers 618 Following Scientific director of Liquid Biopsy & Cancer Interception Group.HUVN-GENyO Founder and Vicepresident of the ISLB
Vivek Subbiah, MD @VivekSubbiah
34K Followers 2K Following Chief, Early-Phase Drug Development|@SarahCannonDocs #Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
ASCO @ASCO
147K Followers 2K Following Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
Pashtoon Kasi MD, MS @pashtoonkasi
18K Followers 11K Following Oncologist | Researcher | ColorectalCancer #CRCSM👨🏼🎓@MayoClinic @PittTweet Alum; 🧬#ctDNA #LiquidBiopsies💡#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO23
OncLive.com @OncLive
44K Followers 2K Following Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
Anirban Maitra @Aiims1742
28K Followers 2K Following Pancreatic cancer researcher and GI pathologist. Striving to improve the lives of patients with cancer. 🇺🇸 🇮🇳
Annals of Oncology @Annals_Oncology
46K Followers 521 Following Medical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.
Journal of Clinical O.. @JCO_ASCO
50K Followers 1K Following @ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, & @JCOPO_ASCO.
chadi nabhan MD, MBA,.. @chadinabhan
19K Followers 783 Following Heme/Onc; NHL/HL/CLL. Adj Professor U of SC; Host: the #HealthcareUnfiltered & the #HemOnc Pulse podcasts. Author of "TOXIC EXPOSURE" & “THE CANCER JOURNEY.”
Petros Grivas @PGrivasMDPhD
16K Followers 12K Following Oncologist, Professor, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch; views are mine
Aakash Desai, MD, MPH @ADesaiMD
5K Followers 1K Following Thoracic/Phase 1 Oncologist @ONealCancerUAB, Asst Prof @UABMedicine | Alum @MayoHemeOnc @UConnIM @MDAndersonNews| Co-Host @HemOncFellows @LungCancerRX
Sara Tolaney @stolaney1
10K Followers 620 Following Chief, Division of Breast Oncology @DanaFarber Tennis fan Mother of two teenage girls
Philippe Aftimos, MD .. @aftimosp
6K Followers 4K Following Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Citizen of wokistan. Ecolo and vegan💚🌱Oud 🎼 💛💙⚽️Views are mine.
Mike Thompson, MD, Ph.. @mtmdphd
23K Followers 4K Following Views my own. VP Clinical Partnerships @TempusLabs #PrecisionMedicine #mmsm #lymsm #CCC19 @COVID19nCCC @ASCO COI: https://t.co/A6GQmWYvau
Targeted Oncology @TargetedOnc
20K Followers 4K Following Oncology news and insights from leading researchers and cancer centers.
Nicole Kuderer, MD, M.. @NicoleKuderer
11K Followers 10K Following Oncologist & Big Data Science (Translational SuppOnc, Toxicity Outcomes Research), #COVID19; @OncoAlert; FASCO, ASCO Biomarkers. “Let's make a difference".
Jun Gong @jgong15
1K Followers 537 Following Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope
Ed Esplin, MD, PhD @EdEsplin
1K Followers 1K Following Clinical Geneticist, MD, PhD, FACMG, CGAF, FACP @ Invitae posts my own
JCO Global Oncology @JCOGO_ASCO
12K Followers 284 Following Cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources. Part of @JCO_ASCO family of journals.
JCO Clinical Cancer I.. @JCOCCI_ASCO
5K Followers 200 Following Clinical research based on biomedical informatics methods applied to cancer-related data, information, and images. Part of @JCO_ASCO family of journals.
Miami Cancer Institut.. @MiamiCancerInst
597 Followers 438 Following Providing quality cancer care in South Florida and aiming for innovative research excellence, part of @BHCancerCare | @BaptistHealthSF
Federica Marmorino @FedericaMarmo18
93 Followers 47 Following Medical Oncologist. University of Pisa. I Tried Being Normal Once. Worst 2 Minutes Of My Life.
Shaalan Beg MD MBA FA.. @ShaalanBeg
7K Followers 6K Following Reimagining cancer clinical trials. Foodie, family guy, digital health. FCOI: https://t.co/CtEt9hUmRB
Sarps_Manuel🇬🇭 @ManuelSarps2
4K Followers 3K Following 🏆ᴛʜɪs ʟɪғᴇ ᴀɪɴᴛ ғᴏʀ ᴛʜᴇ sᴏғᴛ ʜᴇᴀʀᴛᴇᴅ, ᴡᴇ ᴛʀʏ ᴡᴇ ғᴀɪʟ, ᴛʜᴇɴ ᴡᴇ ɢᴏ ʜᴀʀᴅᴇʀ ᴛʜᴀɴ ʙᴇғᴏʀᴇ ɪɴ ᴏʀᴅᴇʀ ᴛᴏ ʜɪᴛ ɪᴛ🏅💯 🔥
Anastasios Maniakas, .. @DrAManiakas
347 Followers 263 Following Assist. Prof. #Headandneck cancer surgeon @MDAndersonNews. @McGillU @UMontreal alumni. #Thyroidcancer and #headandneckcancer clinical+translational research
Romualdo Barroso, MD .. @DrRBarroso
2K Followers 581 Following Medical Oncologist and clinical researcher at DASA Oncology #brasilia. #Breastcancer #Immunotherapy #clinicalresearch. Tweets are my own not medical advice.
Jose Fernando Moura, .. @FernandoOnco
1K Followers 1K Following Medical Oncology focused on Breast and Lung Cancer at https://t.co/hCfxKt8kbP and https://t.co/YeizvuTGR3 Opinions are my own. 🔁not
Arturo LoAIza-Bonilla.. @DrBonillaOnc
5K Followers 6K Following Co-founder @MassiveBio | Director of Oncology Research @capitalhealthnj | Using #tech #AI & #genomics to fight cancer at global scale 🌎 🚀 🧬 🖥️ - My Opinion
Xiuning Le MD PhD @LeXiuning
1K Followers 279 Following Associate Professor Thoracic Head and Neck Medical Oncology MD Anderson Cancer Center
Jill Barnholtz-Sloan,.. @NCIJBSloan
2K Followers 2K Following Official NCI account of Dr. Jill Barnholtz-Sloan, CBIIT Informatics & Data Science Associate Director; DCEG Sr. Investigator, part of @NIH. https://t.co/7z9wLvc4Id
Debyani Chakravarty, .. @CDebyaniPhD
2K Followers 745 Following @OncoKB Lead Scientist @MSKPathology Assistant Member @sloan_kettering cancer biologist. Mother, wife of @JPayneWrites, daughter & sister. tweets are mine.
Dr. Andrew Hendifar @DrHendifar
868 Followers 496 Following I am a physician and scientist working to develop new medications for gastrointestinal malignancies -- particularly pancreatic cancer and neuroendocrine tumors.
Mike Pishvaian @MPishvaian
5K Followers 1K Following GI Onc at Hopkins, focusing on #PancreaticCancer, #PrecisionMedicine. Striving to improve patient outcomes. Originator of #TumorBoardTuesday @TumorBoardTues
Eileen M O’Reilly @EileenMOReilly
6K Followers 3K Following Oncologist MSK. TCD alum. Interests Pancreas, Hepatobiliary, GI Cancers, IRB Chair, Editor, Data & safety, Drug Development, Clinical trials, Alliance GI, NCTN
Remond Fijneman @rjafijneman
65 Followers 47 Following
Jonathan Evan Shoag �.. @jeshoag
355 Followers 300 Following Urologist- Scientist, Penn, Harvard-MIT alum, former Weill Cornell resident and fellow, University Hospitals Cleveland Case Comprehensive Cancer Center
Randy Vince Jr. @randy_vincejr
815 Followers 164 Following West Baltimore Native, Urologic Oncologist and Director of Minority Men’s Health @caseurology “If there is no struggle there is no progress” Fredrick Douglass
Chris Barbieri @Chris_Barbieri1
2K Followers 927 Following Urologic Oncologist, #prostatecancer translational researcher, husband, father, Eagles fan. Views my own. RT≠E
Daniel E Spratt @DrSpratticus
10K Followers 519 Following Vincent Smith Professor and Chair of Radiation Oncology University Hospitals Seidman Cancer Center Case Western Reserve University SOM. *TWEETS are my own*
Spyros Basourakos @SBasourakos
415 Followers 695 Following @UroOnc Fellow at @MayoUrology | Residency at @WCMUrology | Former researcher at @MDAndersonNews | Views my own | 🇬🇷
Daniel Stover, MD, FA.. @StoverLab
5K Followers 2K Following Breast cancer physician-scientist | Clinical computational oncology @OSUCCC_James | Vice Chair, @Alliance_org Breast Cmte | Views own | https://t.co/43RiVpzkfP
Katharine Collier, MD @katecollier_md
228 Followers 500 Following GU medical oncologist and physician-scientist focused on #bladdercancer | Assistant Professor @OSUCCC_James @OhioState | Views my own
Wilmot Cancer Institu.. @WilmotCancer
3K Followers 912 Following The Wilmot Cancer Institute is the leader in cancer care and research in the greater Rochester and Finger Lakes Region.
JCO Oncology Practice @JCOOP_ASCO
14K Followers 332 Following Impactful information & insights to changes & challenges inherent in delivering equitable, high-quality oncology care. Part of @JCO_ASCO family of journals.
Foregut Team NIH @NCICCR_Foregut
737 Followers 693 Following Official Twitter account of the NIH Foregut Team. (Esophageal, stomach, pancreas & hepatobiliary tumors.) [email protected] Privacy: https://t.co/47s9FxzVVe
Sarah Silvergleid @silver_gleid
73 Followers 807 Following
Lucia Pia Ciccone, MD @LpCiccone
1K Followers 2K Following Radiation Oncologist - neuro-oncology Centro Nazionale di Adroterapia Oncologica (CNAO)
Claudia Cardone @clacardone
1K Followers 1K Following MD, PhD. GI Medical Oncologist @istitutotumori. #MCCR17. @myesmo. Neapolitan. European. #endowarrior 🎗️. Tweets are my own.
Ryan Caddell, PharmD,.. @TexBuckeyeBCOP
580 Followers 3K Following Heme/Onc | @Buckeyes | @Dallascowboys | @OhioState PharmD | #WVU PGY-1 | Prior Malignant Hematology & PGY2 @Moffittnews & Heme/Onc @ Baycare & TGH. Tweets = Own
Johnathan Ebben MD, P.. @JohnEbbenMDPhD
1K Followers 2K Following Oncology Fellow. Scientist. Entrepreneur. Turning basic science into medicine. Crowdsourcing precision oncology wisdom with @TumorBoardTues
Eli Van Allen @VanAllenLab
9K Followers 2K Following Clinical Computational Oncology @DanaFarber @harvardmed @broadinstitute | Chief - Population Sciences | Prev.: @Stanford @UCLA @UCSF | Discl.: https://t.co/EmrHxvg76N
Children's National H.. @ChildrensNatl
38K Followers 4K Following We don’t want kids to just grow up, we want them to #GROWUPSTRONGER. Official feed for Children's National Hospital.
Oncology Nursing News @OncNursingNews
10K Followers 711 Following Capturing the voice of nursing professionals in the oncology news landscape.
NCI Media Relations @NCIMedia
41K Followers 465 Following Official Twitter account of the NCI Media Relations Branch, which supports journalists & writers reporting on cancer research (privacy: https://t.co/47s9FxzVVe )
Moffitt Cancer Center @MoffittNews
50K Followers 4K Following Moffitt Cancer Center is a global leader in patient care, research and education with a mission to contribute to the prevention and cure of cancer.
The Cancer Letter @TheCancerLetter
26K Followers 2K Following The leading independent source for information on the issues that shape #oncology since 1973. Editor: @PaulBGoldberg | Historical initiative: @cancerhistproj
Oncology Nursing Soci.. @oncologynursing
25K Followers 126 Following Professional association of more than 35,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care.@priyanka_kanth @ClinicalLung @priyanka_kanth Great question. In our @JCOPO_ASCO study (ascopubs.org/doi/10.1200/PO…) 87 #lungcancer #patients had PGVs in #Lynchsyndrome genes. We're working on #somatictesting of tumors from #lungcancer #patients to assess which might be #Lynchsyndrome driven. Stay tuned...
Rare Pediatric Invasive Gliofibroma Has BRAFV600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution [Mar 27, 2019] @KanevaMD et al. @JCOPO_ASCO ow.ly/isF750I3NcZ #PrecisionMedicine #btsm
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures [Jun 8, 2022] @kabir_mody et al. @MarkYarchoan @JCOPO_ASCO ascopubs.org/doi/full/10.12… #hpbcsm #PrecisionMedicine
Rare Pediatric Invasive Gliofibroma Has BRAFV600E Mutation and Transiently Responds to Targeted Therapy Before Progressive Clonal Evolution [Mar 27, 2019] @KanevaMD et al. @JCOPO_ASCO ow.ly/isF750I3NcZ #PrecisionMedicine #btsm
'...we are likely underestimating the prevalence of the inherited risk for #lungcancer. Utilization of #universal #germlinetesting can increase the detection of clinically actionable #germline variants over the guideline-based approach.' @ClinicalLung clinical-lung-cancer.com/article/S1525-… c/w…
.@jgong15 @CSCancerCenter publishing amazing research in @JCOPO_ASCO!
1/2 Dual publication @JCOPO_ASCO @theNCI @eaonc NCI-MATCH Subprotocol K2 positive PhII trial ➡️ activity of #Erdafitinib in treatment-refractory tumors w/#FGFR1-3 mutations or fusions, adding to evid for potential tumor agnostic indication? ascopubs.org/doi/10.1200/PO… @OncoAlert
🚨Thanks Dr Rafeq Naqash @thenasheffect for the kind invitation to @JCOPO_ASCO conversations podcast 🎤on our paper📝“Liquid Biopsy of Lung Cancer Before Path Diagnosis” @Al3ssandroRusso @lpasquina @ASCO sites.libsyn.com/427415/liquid-…
@isliquidbiopsy @TischCancer @ASCO @JCOPO_ASCO
🚨Thanks Dr Rafeq Naqash @thenasheffect for the kind invitation to @JCOPO_ASCO conversations podcast 🎤on our paper📝“Liquid Biopsy of Lung Cancer Before Path Diagnosis” @Al3ssandroRusso @lpasquina @ASCO sites.libsyn.com/427415/liquid-…
Quantifying the Value of Molecular Tumor Board: Discordance Rec Rate & Drug Cost Avoidance [Oct 20, 2022] @mkwalters305 et al. @JCOPO_ASCO ascopubs.org/doi/abs/10.120… #PrecisionMedicine #hpeonc Table 2
Implementation & Utility of an Integrated Academic-Community #PrecisionMedicine MTB [Jul 5, 2017] @meburkard et al. @JCOPO_ASCO ow.ly/7Gln30dvnrx
@VivekSubbiah @jgong15 @JCOPO_ASCO #ASCO24 entrance @VivekSubbiah 😎
1/2 Dual publication @JCOPO_ASCO @theNCI @eaonc NCI-MATCH Subprotocol K2 positive PhII trial ➡️ activity of #Erdafitinib in treatment-refractory tumors w/#FGFR1-3 mutations or fusions, adding to evid for potential tumor agnostic indication? ascopubs.org/doi/10.1200/PO… @OncoAlert
2/2 Dual publication @JCOPO_ASCO @theNCI @eaonc NCI-MATCH Subprotocol K1 PhII trial ➡️ no activity (0% ORR) of #Erdafitinib in tumors w/#FGFR1-4 amplifications, informative that not all #FGFR alterations may be targetable ascopubs.org/doi/10.1200/PO… @OncoAlert @JCO_ASCO @ASCOPost
@jgong15 Nice work. Congrats on the back to back publications @JCOPO_ASCO 👏🏼
Quantifying the Value of Molecular Tumor Board: Discordance Recommendation Rate & Drug Cost Avoidance [10/20/22] @mkwalters305 @JimW9200 @antonyruggeri @mullane_michael Hunt, Wilson, Ramczyk, @mtmdphd @JCOPO_ASCO ascopubs.org/doi/abs/10.120… #PrecisionMedicine #hpeonc @Aurora_Cancer
Quantifying the Value of Molecular Tumor Board: Discordance Rec Rate & Drug Cost Avoidance [Oct 20, 2022] @mkwalters305 et al. @JCOPO_ASCO ascopubs.org/doi/abs/10.120… #PrecisionMedicine #hpeonc Table 1. Recommendation Discordance Definition
Quantifying the Value of Molecular Tumor Board: Discordance Rec Rate & Drug Cost Avoidance [Oct 20, 2022] @mkwalters305 et al. @JCOPO_ASCO ascopubs.org/doi/abs/10.120… #PrecisionMedicine #hpeonc Table 2
Our recent publication clinically validating PROphet® #NSCLC is now the top feature in @JCOPO_ASCO! If you haven't read it yet, now's the time: ascopubs.org/doi/10.1200/PO… #liquidbiopsy #proteomics #biomarker #precisiononcology @drgandara @APDicker @ChrisDingmanCCO @oferorama
Happy to share our work in @JCOPO_ASCO on real-world OS & Tx patterns by PTEN status in met #CSPC using @flatironhealth PTEN LOF ass w/ significantly ⬇️OS vs intact PTEN regardless of 1L Tx @RyonGraf @CleClinicMD @neerajaiims @montypal @PCF_Science pubmed.ncbi.nlm.nih.gov/38547419/
Excited to share our work on “Identification of Pancreatic Cancer Germline Risk Variants With Effects That Are Modified by Smoking”, published today in JCO Precision Oncology @JCOPO_ASCO ascopubs.org/doi/10.1200/PO…
Trends for United States
You might like
